Diabetes
News
FDA approves first interchangeable biosimilar insulin
The approval will allow Semglee to function like a generic drug in the market and may reduce insulin costs.
From the Journals
PCPs lag on albuminuria tests in patients with type 2 diabetes
From the Journals
More on GRADE: Cognitive deficits linked to CV risk factors in T2D
Hyperlipidemia and hypertension predict modest cognitive impairment even in diabetes of limited duration, but one expert urges caution: “The...
From the Journals
Diabetes duration linked to increasing heart failure risk
Diabetes duration of 15 years or more is tied to a tripled incident heart failure rate, 20-year follow-up on nearly 10,000 U.S. adults shows.
PURLs
This is not the time to modify a HTN regimen
Intensifying hypertension regimens at discharge increases risk in older patients.
Feature
Call to Action: Multidisciplinary panel urges coordinated care for ‘NASH epidemic’
From the Journals
Dapagliflozin safe, protective in advanced kidney disease
“This is now the absolute reassurance that we do not have to stop an SGLT2 inhibitor in people with eGFR< 30 mL/min for safety reasons” and...
News
FDA okays extended-release exenatide for children with T2D
It’s the second GLP-1 receptor agonist approved for youth with type 2 diabetes, and the first once-weekly.
From the Journals
‘Wild West’ and weak evidence for weight-loss supplements
News
FDA OKs spinal cord stimulation for diabetic neuropathy pain
From the Journals
Analysis supports CAC for personalizing statin use
A cross-sectional study confirms a coronary artery calcium score of 0 may obviate the need for statins in the context of risk-enhancing factors....